Solid Biosciences financial statements

솔리드 바이오사이언시스NASDAQ:SLDB · Nasdaq · Healthcare · sector #17
$6.92-1.98%
2026-10-06 close

Solid Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$130M.

Reported results

Solid Biosciences notifications

Quantus Signal · live data · not investment advice · Privacy Policy